Mark Daniels

Mark Daniels has over 20 years of experience in the clinical research field. Mark began their career in 1997 as a CRA at Quintiles. Mark then worked at Elan as a Clinical Research Manager from 2002 to 2007, followed by a role as Director of Clinical Operations at Cebix, Inc. from 2011 to 2015. From 2015 to 2018, they worked as Director, Clinical Development at ViaCyte, and then as Sr. Director, Clinical Development at the same company until 2022. Currently, Mark Daniels is Vice President Clinical Operations at Design Therapeutics.

Mark Daniels obtained a BS in Psychobiology from the University of California, Los Angeles between 1992 and 1997. Mark also holds the CCRA certification from the ACRP.